178 related articles for article (PubMed ID: 19661844)
1. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer.
Yuh WT; Mayr NA; Jarjoura D; Wu D; Grecula JC; Lo SS; Edwards SM; Magnotta VA; Sammet S; Zhang H; Montebello JF; Fowler J; Knopp MV; Wang JZ
Invest Radiol; 2009 Jun; 44(6):343-50. PubMed ID: 19661844
[TBL] [Abstract][Full Text] [Related]
2. Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.
Mayr NA; Yuh WT; Jajoura D; Wang JZ; Lo SS; Montebello JF; Porter K; Zhang D; McMeekin DS; Buatti JM
Cancer; 2010 Feb; 116(4):903-12. PubMed ID: 20052727
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Grecula JC; Lo SS; Jaroura D; Montebello J; Zhang H; Li K; Lu L; Huang Z; Fowler JM; Wu DH; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):502-8. PubMed ID: 19775824
[TBL] [Abstract][Full Text] [Related]
4. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model.
Mayr NA; Huang Z; Wang JZ; Lo SS; Fan JM; Grecula JC; Sammet S; Sammet CL; Jia G; Zhang J; Knopp MV; Yuh WT
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):972-9. PubMed ID: 22208967
[TBL] [Abstract][Full Text] [Related]
5. Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction.
Huang Z; Yuh KA; Lo SS; Grecula JC; Sammet S; Sammet CL; Jia G; Knopp MV; Wu Q; Beauchamp NJ; Yuh WT; Wang R; Mayr NA
Magn Reson Imaging; 2014 Dec; 32(10):1198-205. PubMed ID: 25179141
[TBL] [Abstract][Full Text] [Related]
6. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
8. Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
Hawighorst H; Knapstein PG; Knopp MV; Vaupel P; van Kaick G
MAGMA; 1999 Mar; 8(1):55-62. PubMed ID: 10383094
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer.
Mayr NA; Wang JZ; Zhang D; Montebello JF; Grecula JC; Lo SS; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1513-21. PubMed ID: 19286329
[TBL] [Abstract][Full Text] [Related]
10. Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.
Huang Z; Mayr NA; Lo SS; Grecula JC; Wang JZ; Jia G; Yuh WT
J Cancer Sci Ther; 2012 Sep; 4(9):254-259. PubMed ID: 23638244
[TBL] [Abstract][Full Text] [Related]
11. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging.
Mayr NA; Taoka T; Yuh WT; Denning LM; Zhen WK; Paulino AC; Gaston RC; Sorosky JI; Meeks SL; Walker JL; Mannel RS; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):14-22. PubMed ID: 11777618
[TBL] [Abstract][Full Text] [Related]
12. Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma.
Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
Eur Radiol; 2017 Jul; 27(7):3069-3079. PubMed ID: 27957638
[TBL] [Abstract][Full Text] [Related]
13. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer.
Mayr NA; Wang JZ; Lo SS; Zhang D; Grecula JC; Lu L; Montebello JF; Fowler JM; Yuh WT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):719-27. PubMed ID: 19632061
[TBL] [Abstract][Full Text] [Related]
14. Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Larsson C; Groote I; Vardal J; Kleppestø M; Odland A; Brandal P; Due-Tønnessen P; Holme SS; Hope TR; Meling TR; Fosse E; Emblem KE; Bjørnerud A
Magn Reson Imaging; 2020 May; 68():106-112. PubMed ID: 32004711
[TBL] [Abstract][Full Text] [Related]
15. Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery-the "PRICE" study 2: role of conventional and DW-MRI.
Gui B; Miccò M; Valentini AL; Cambi F; Pasciuto T; Testa A; Autorino R; Zannoni GF; Rufini V; Gambacorta MA; Giordano A; Scambia G; Manfredi R
Eur Radiol; 2019 Apr; 29(4):2045-2057. PubMed ID: 30324389
[TBL] [Abstract][Full Text] [Related]
16. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
17. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
18. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer.
Mayr NA; Yuh WT; Arnholt JC; Ehrhardt JC; Sorosky JI; Magnotta VA; Berbaum KS; Zhen W; Paulino AC; Oberley LW; Sood AK; Buatti JM
J Magn Reson Imaging; 2000 Dec; 12(6):1027-33. PubMed ID: 11105046
[TBL] [Abstract][Full Text] [Related]
19. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay.
Mayr NA; Yuh WT; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Davis CS; Wen BC; Martin DD; Pelsang RE; Buller RE; Oberley LW; Mellenberg DE; Hussey DH
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):623-33. PubMed ID: 8948347
[TBL] [Abstract][Full Text] [Related]
20. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
